Crossmark

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

Crossref DOI link: https://doi.org/10.1186/s12885-023-11070-3

Published Online: 2023-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Ai

Guan, Shasha

Sun, Yinjuan

Wang, Lingling

Meng, Fanlu

Liu, Xia

Gu, Liyan

Li, Guo

Zhong, Diansheng

Zhang, Linlin
Funding

Funding for this research was provided by:

National Nature Science Foundation of China (82103045, 82000113, 82103045, 82000113)

Medical Research and Development Foundation (TB211003)
License Information

Text and Data Mining valid from 2023-07-01

Version of Record valid from 2023-07-01
More Information

Article History

Received: 6 November 2022

Accepted: 14 June 2023

First Online: 1 July 2023

Declarations

:

: The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of Tianjin Medical University General Hospital. Written informed consent was obtained from individual or guardian participants. They were mentioned in the Result part.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below